Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |